Le Lézard
Classified in: Health
Subjects: SVY, WOM, POL

New Survey Study Asks Questions about Government-Funded IVF in Ontario


MONTREAL, Sept. 25, 2017 /CNW/ - As announced at the Annual Meeting of the Canadian Fertility and Andrology Society (CFAS), this week marks the official launch of a survey study that will probe the impact of Ontario government-funded IVF on patients taking part in the program to build their families, and on staff working in the Ontario-based fertility sector. The study is open to all fertility clinic staff in Ontario, and IVF patients who have had, are receiving, or are waiting for their OHIP funded cycle. It will be accessible at all Ontario-based clinics, as well as on the websites and social media platforms of fertilitymatters.ca, cfas.ca and OntarioFertility.ca.

"This new funding has changed the landscape of the way fertility services are delivered in the province and we need to understand those changes and how they impact our patients and our staff," said one of the principal investigators, Carl A. Laskin MD, FRCPC.

The survey study link will be active for 8 weeks from launch. The Applied Health and Research Centre (AHRC) at St. Michael's Hospital has been hired to collect and analyze the survey responses.

Results of the study will be submitted through the CFAS for presentation in early 2018.

 

SOURCE Canadian Fertility and Andrology Society (CFAS)


These press releases may also interest you

at 14:08
Seacoast Laboratory Data Systems, a nationwide leader in providing customizable LIS and AR software solutions for commercial and...

at 14:05
The Atrium at Cardinal Drive, a Benchmark Mind & Memory Care community, has ranked among the best assisted living with memory care communities in Massachusetts and the entire U.S. for the second straight year. In U.S. News & World Report's third...

at 14:04
The Association for Diagnostics & Laboratory Medicine (ADLM, formerly AACC) is proud to announce the recipients of the 2024 ADLM and Academy of Diagnostics & Laboratory Medicine Awards. Through this annual awards program, ADLM and its Academy...

at 14:04
Today, the U.S. Food and Drug Administration approved Pivya (pivmecillinam) tablets for the treatment of female adults with uncomplicated urinary tract infections (UTIs) caused by susceptible isolates of Escherichia coli, Proteus mirabilis and...

at 14:00
Help at Home, the leading national provider of innovative, high-quality, home care services, today announced that it is encouraged by the Administration's continued recognition of the value of the home care industry and its critical role in support...

at 13:46
Cresilon Inc. ("Cresilon"), a Brooklyn-based biotechnology company focused on hemostatic medical device technologies, today announced it has entered into distribution agreements for VETIGEL® to be sold through several leading regional distributors of...



News published on and distributed by: